The government has agreed to purchase 7.6 million doses from AstraZeneca (enough to vaccinate 3.8 million people) and 10.72 million doses from Novavax (for 5.36 million people). Today’s announcement builds on the government’s existing agreement to purchase 1.5 million doses of the Pfizer/BioNTech vaccine (for 750,000 people) and an in-principle agreement to purchase up to 5 million COVID-19 vaccines from Janssen Pharmaceutica (for 5 million people).
This is a companion discussion topic for the original entry at https://www.sciencemediacentre.co.nz/2020/12/17/covid-19-vaccine-portfolio-rounded-out-expert-reaction/